Multiple Sclerosis (MS) Market Research Reports & Industry Analysis
The prevalence rate of MS in the United States is approximately 57.8 per 100,000. Above the 37th parallel, the prevalence is reported at 68.8 per 100,000, and below it, it is reported at 35.5 per 100,000 Scientists continue their extensive efforts to create new and better therapies for MS. One of the most promising MS research areas involves naturally occurring antiviral proteins known as interferons. Beta interferon has been shown to reduce the number of exacerbations and may slow the progression of physical disability.
When attacks do occur, they tend to be shorter and less severe. In addition, there are a number of treatments under investigation that may curtail attacks or improve function. Over a dozen clinical trials testing potential therapies are underway, and additional new treatments are being devised and tested in animal models. There are a variety of treatments for M.S. which are indicated to slow the progress of the disease.
Multiple Sclerosis (MS) Industry Research & Market Reports
-
Anti-inflammatory Drugs Market Size, Share, and Analysis, By Drug Type (Nonsteroidal Anti-inflammatory Drugs (NSAIDs), Immune Selective Anti-inflammatory Derivatives, Anti-inflammatory Biologics, and Corticosteroids), By Application (Arthritis, Chronic Obstructive Pulmonary Disease, Multiple Sclerosis, Inflammatory Bowel Disease (IBD), and Others), By Route of Administration (Oral, Topical, Injection, and Inhalation), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By Region (North America, Europe, Asia-Pacific, and Rest of the World), And Regional Forecast 2024-2034
... and Others), By Route of Administration (Oral, Topical, Injection, and Inhalation), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By Region (North America, Europe, Asia-Pacific, and Rest of the World), And Regional Forecast ... Read More
-
Relapsing Remitting Multiple Sclerosis Market
... therapies. The market is projected to grow at a CAGR of 3.1% during the forecast period of 2024-2032, and likely to reach a value of 7.6 billion by 2032. Relapsing Remitting Multiple Sclerosis Market Analysis ... Read More
-
Global Active Wheelchair Market Size, Share & Trends Analysis by Type (Manual Wheelchair, Powered Wheelchair), by Indication (Cerebral Palsy, Alzheimer’s Disease, Multiple Sclerosis), and Regional Forecasts 2022–2032
... witness significant growth, with the market size estimated at USD 1.58 billion in 2023 and projected to expand at a CAGR of 5.8% during the forecast period from 2024 to 2032. These mobility aids are ... Read More
-
PEGylated Proteins Market Report by Product (Consumables, Services), Protein Type (Colony Stimulating Factors, Interferons, Erythropoietin, mAbs, Recombinant Factor VII, and Others), Application (Cancer Treatment, Hepatitis, Chronic Kidney Diseases, Hemophilia, Multiple Sclerosis, Gastrointestinal Disorders, and Others), End User (Pharmaceutical and Biotechnology Companies, Contract Research Organizations, Academic and Research Institutes), and Region 2025-2033
... End User (Pharmaceutical and Biotechnology Companies, Contract Research Organizations, Academic and Research Institutes), and Region 2025-2033 The global PEGylated proteins market size reached USD 1.4 Billion in 2024. Looking forward, IMARC Group expects the market ... Read More
-
Neurorehabilitation Devices Market Analysis and Forecast To 2033: By Type (Wearable Devices, Non-Invasive Stimulators, Brain-Computer Interface, Robotic Systems, Neuroprosthetics, Neurofeedback Systems), Product (Neurostimulation Devices, Neurorehabilitation Apps, Therapeutic Devices, Biofeedback Devices, Cognitive Training Tools), Services (Rehabilitation Therapy, Consultation Services, Training and Education, Maintenance and Support), Technology (Artificial Intelligence, Virtual Reality, Augmented Reality, Machine Learning, Internet Of Things, Cloud Computing), Application (Stroke Rehabilitation, Traumatic Brain Injury, Parkinson'S Disease, Multiple Sclerosis, Cerebral Palsy, Spinal Cord Injury), End User (Hospitals, Clinics, Rehabilitation Centers, Home Care Settings, Research Institutes), Device (Exoskeletons, Hand Function Systems, Gait Trainers, Balance Systems), Functionality (Motor Skills Enhancement, Cognitive Function Improvement, Speech Therapy, Vision Rehabilitation), Solut
... Therapy, Consultation Services, Training and Education, Maintenance and Support), Technology (Artificial Intelligence, Virtual Reality, Augmented Reality, Machine Learning, Internet Of Things, Cloud Computing), Application (Stroke Rehabilitation, Traumatic Brain Injury, Parkinson'S Disease, Multiple Sclerosis, Cerebral Palsy, ... Read More
-
Innovation Insights: B-cell Depletion
... used to treat conditions like rheumatoid arthritis, multiple sclerosis, and systemic lupus erythematosus. B cells contribute to disease by producing autoantibodies, presenting antigens, and secreting cytokines. Therapies often target CD20, a marker on B cells, ... Read More
-
Global Stem Cell Therapy for Multiple Sclerosis Market Growth (Status and Outlook) 2024-2030
... million in 2023. With growing demand in downstream market, the Stem Cell Therapy for Multiple Sclerosis is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. ... Read More
-
Multiple Sclerosis Market in US 2025-2029
... the multiple sclerosis market in us provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding ... Read More
-
Global Multiple Sclerosis Treatment Market Growth (Status and Outlook) 2024-2030
... demand in downstream market, the Multiple Sclerosis Treatment is forecast to a readjusted size of US$ 19060 million by 2030 with a CAGR of 2.1% during review period. The research report highlights the growth potential ... Read More
-
PEGylated Proteins Market Size, Share, By Type (Consumables, and Services), By Protein (Colony-stimulating factor, Interferons, Erythropoietin, Recombinant factor VII, and Other), By Application (Cancer, Autoimmune Disease, Hepatitis, Multiple Sclerosis, Hemophilia, Gastrointestinal Disorder, and Others), By End-User (Pharmaceutical & Biotechnology Companies, Contract Research Organizations, and Academic and Research Institutes), and By Region - Trends, Analysis and Forecast till 2034
... End-User (Pharmaceutical & Biotechnology Companies, Contract Research Organizations, and Academic and Research Institutes), and By Region - Trends, Analysis and Forecast till 2034 PEGylated Proteins Market is experiencing significant growth, driven by increasing demand for ... Read More
-
Global Stem Cell Therapy for Multiple Sclerosis Market 2024 by Company, Regions, Type and Application, Forecast to 2030
... size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period. Multiple sclerosis is a nervous system disease, ... Read More
-
Global Targeted Drugs for Multiple Sclerosis Market Growth (Status and Outlook) 2024-2030
... it is expected to grow at a CAGR of %from 2024 to 2030. LPI (LP Information)' newest research report, the “Targeted Drugs for Multiple Sclerosis Industry Forecast” looks at past sales and reviews total world ... Read More
-
Neuromuscular Electric Stimulator Market
... by technological advancements, the increasing prevalence of musculoskeletal disorders, and a rising demand for effective rehabilitation solutions. The shift towards personalized and home-based treatments, fueled by innovations in portable neuromuscular stimulators, further propels the market ... Read More
-
Stem Cell Therapy for Multiple Sclerosis Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type
... Sclerosis from 2019 to 2023 and its CAGR from 2019 to 2023, and also forecasts its market size to the end of 2029 and its CAGR from 2024 to 2029. For geography segment, regional supply, ... Read More
-
Global Multiple Sclerosis Drugs Treatment Market Growth (Status and Outlook) 2024-2030
... growing demand in downstream market, the Multiple Sclerosis Drugs Treatment is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth ... Read More
-
Global Multiple Sclerosis Therapeutics Market Growth (Status and Outlook) 2024-2030
... demand in downstream market, the Multiple Sclerosis Therapeutics is forecast to a readjusted size of US$ 19240 million by 2030 with a CAGR of 2.1% during review period. The research report highlights the growth potential ... Read More
-
Global Secondary Progressive Multiple Sclerosis Drug Market Growth 2024-2030
... demand in downstream market, the Secondary Progressive Multiple Sclerosis Drug is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth ... Read More
-
Global Primary Progressive Multiple Sclerosis Treatment Market Growth (Status and Outlook) 2024-2030
... 2023. With growing demand in downstream market, the Primary Progressive Multiple Sclerosis Treatment is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report ... Read More
-
Global Progressive Relapsing Multiple Sclerosis Treatment Market Growth (Status and Outlook) 2024-2030
... 2023. With growing demand in downstream market, the Progressive Relapsing Multiple Sclerosis Treatment is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report ... Read More
-
U.S. IVD And LDT For Autoimmune Diseases Market Size, Share & Trends Analysis Report By Type (IVD, LDT), By Technology (Immunoassays, Clinical Chemistry, Hematology, Coagulation, Microbiology), By Application, By Country, And Segment Forecasts, 2024 - 203
... 2030 U.S. IVD And LDT For Autoimmune Diseases Market Growth & Trends The U.S. IVD and LDT for autoimmune diseases market size is expected to reach USD 3.70 billion by 2030, growing at a CAGR ... Read More
-
Neurorehabilitation Devices Market Report by Product Type (Neurorobotic Devices, Wearable Devices, Non-Invasive Stimulators, Brain-Computer Interface), Application (Stroke, Multiple Sclerosis, Parkinson's Disease, Cerebral Palsy, and Others), End User (Hospitals and Clinics, Cognitive Care Centers, and Others), and Region 2024-2032
... and Region 2024-2032 The global neurorehabilitation devices market size reached US$ 1.9 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 4.3 Billion by 2032, exhibiting a growth rate (CAGR) of ... Read More
-
Neurological Biomarkers Market Report by Type (Genomic Biomarkers, Proteomic Biomarkers, Metabolomic Biomarkers, Imaging Biomarkers, and Others), Application (Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis, Autism Spectrum Disorders, and Others), End Use (Hospital Laboratories, Clinical Diagnostic Centers, Research Organizations, and Others), and Region 2024-2032
... Research Organizations, and Others), and Region 2024-2032 The global neurological biomarkers market size reached US$ 8.9 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 24.0 Billion by 2032, exhibiting a ... Read More
-
Neurodegenerative Disease Treatment Market Report by Indication (Multiple Sclerosis, Parkinson’s Disease, Alzheimer’s Disease, Spinal Muscular Atrophy (SMA), Huntington’s Disease, and Others), Drug Type (N-Methyl-D-Aspartate Receptor Antagonists, Selective Serotonin Reuptake Inhibitors, Dopamine Inhibitors, and Others), Route of Administration (Oral, Injectable, and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Others), and Region 2024-2032
... of Administration (Oral, Injectable, and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Others), and Region 2024-2032 The global neurodegenerative disease treatment market size reached US$ 74.7 Billion in 2023. Looking forward, IMARC Group expects ... Read More
-
Multiple Sclerosis Therapies Market Report by Drug (Immunomodulators, Immunosuppressants), Drug Type (Biologic Drugs, Small Molecule Drugs), Route of Administration (Oral, Injectable, Intravenous), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Region 2024-2032
... multiple sclerosis therapies market size reached US$ 26.9 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 37.8 Billion by 2032, exhibiting a growth rate (CAGR) of 3.7% during 2024-2032. Multiple ... Read More
-
Auto-Injectors Market Size, Share, & Trends Analysis By Type (Disposable, Reusable), By Disease Indication (Rheumatoid Arthritis, Multiple Sclerosis), By End Use, By Region, And Segment Forecasts, 2024 - 2030
... global auto-injectors market size was estimated at USD 20.59 billion in 2030 and is projected to grow at a CAGR of 14.4% from 2024 to 2030. Rising incidence of anaphylactic shock and other diseases such ... Read More
Research Assistance
